Official UK procurement notice
Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion
Authority: NHS Blood and Transplant (Central government)
What is being bought
Published requirement descriptionNHS Blood and Transplant (NHSBT) invites expressions of interest from potential suppliers (of an existing product) or manufacturers capable of manufacturing any approved red cell storage solution, for example (but not limited to) SAG-M (Saline-Adenine-Glucose-Mannitol) or PAGGSM (Phosphate-Adenine-Glucose-Guanylate-Saline-Mannitol), for Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion. Washed components must meet the requirements of Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK, section 7.3.3. which can be found here: www.transfusionguidelines.org/red-book/chapter-7/7… ↗ This engagement aims to assess market capability, capacity, and interest in supplying a sterile, labelled product. Requirement Interested parties must be able to supply or manufacture additive solution bags that meet the following criteria: - Solution Type: SAG-M or PAGGSM or other approved red cell storage solution - Sterility: Bags must be sterile and suitable for clinical use - Design: Each bag must include a pigtail for sterile docking - Labeling: Bags must be clearly and accurately labelled in accordance with applicable regulatory standards - Compatibility: The solution must be suitable for use in NHSBTs red blood cell washing processes Supplier Engagement Objectives Through this engagement, NHSBT seeks to: - Understand the current market landscape and supplier capabilities - Identify potential suppliers for future procurement opportunities - Gather feedback on product availability, lead times, and regulatory compliance Next Steps Suppliers interested in participating in this market engagement are invited to express their interest by contacting samantha.rix@nhsbt.nhs.uk . Further information, including a questionnaire or Request for Information (RFI), may be issued following initial expressions of interest. No business whatsoever is guaranteed under any resulting framework or contract, and there is no guarantee that any framework or contract will be put in place in relation to this notice. Each Potential Supplier is responsible for all costs and expenses incurred in relation to this Market Engagement exercise, each Potential Supplier accepts by its participation in this process, including without limitation the submission of any documents or attending meetings, that it will not be entitled to claim from NHSBT any costs, expenses or liabilities that it may incur irrespective of whether or not its tender is successful or if a tender or resulting framework or contract is withdrawn for any reason.
CPV: Blood bags · Blood substitutes and perfusion solutions · Blood-transfusion supplies · Chemical products · Medical solutions · Pharmaceutical products · Specialised chemical products
The lotProcurement structure
single lot · no lot value publishedProcedure terms & legal framework
From the official record- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Past planning notice
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 1 Apr 2025, 14:48 BST
- Last source update
- 20 May 2025, 07:40 BST
- Authority reference
C351077- FTS notice number
2025/S 000-022921- Latest notice
- Preliminary market engagement notice (UK2)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04fb6dFind a Tender
How it was run
Official notice- Submission deadline
- —
Timeline
1 Apr 2025 → 1 Nov 2026 · 5 dates- Planning notice published1 Apr 2025, 14:48 BST
- Latest notice published20 May 2025, 07:40 BST
- Market engagement30 Jun 2025, 23:59 BST
NHS Blood and Transplant (NHSBT) invites expressions of interest from potential suppliers (of an existing product) or manufacturers capable of manufacturing any approved red cell storage solution, for example (but not limited to) SAG-M (Saline-Adenine-Glucose-Mannitol) or PAGGSM (Phosphate-Adenine-Glucose-Guanylate-Saline-Mannitol), for Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion. Washed components must meet the requirements of Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK, section 7.3.3. which can be found here: www.transfusionguidelines.org/red-book/chapter-7/7… ↗ This engagement aims to assess market capability, capacity, and interest in supplying a sterile, labelled product. Requirement Interested parties must be able to supply or manufacture additive solution bags that meet the following criteria: - Solution Type: SAG-M or PAGGSM or other approved red cell storage solution - Sterility: Bags must be sterile and suitable for clinical use - Design: Each bag must include a pigtail for sterile docking - Labeling: Bags must be clearly and accurately labelled in accordance with applicable regulatory standards - Compatibility: The solution must be suitable for use in NHSBTs red blood cell washing processes Supplier Engagement Objectives Through this engagement, NHSBT seeks to: - Understand the current market landscape and supplier capabilities - Identify potential suppliers for future procurement opportunities - Gather feedback on product availability, lead times, and regulatory compliance Next Steps Suppliers interested in participating in this market engagement are invited to express their interest by contacting samantha.rix@nhsbt.nhs.uk . Further information, including a questionnaire or Request for Information (RFI), may be issued following initial expressions of interest. No business whatsoever is guaranteed under any resulting framework or contract, and there is no guarantee that any framework or contract will be put in place in relation to this notice. Each Potential Supplier is responsible for all costs and expenses incurred in relation to this Market Engagement exercise, each Potential Supplier accepts by its participation in this process, including without limitation the submission of any documents or attending meetings, that it will not be entitled to claim from NHSBT any costs, expenses or liabilities that it may incur irrespective of whether or not its tender is successful or if a tender or resulting framework or contract is withdrawn for any reason.
- Tender notice expected210 days ago1 Apr 2026, 23:59 BST
- Today29 Oct 2026
- Contract startsin 2 days1 Nov 2026
Notice history
3 events · 4 releases on Find a Tender · since 1 Apr 2025- Preliminary market engagement notice published1 Apr 2025, 14:48 BSTUK2
- Preliminary market engagement notice published19 May 2025, 08:49 BSTUK2
- Preliminary market engagement notice published20 May 2025, 07:40 BSTUK2
Published amendments (1)
Amending the Notice to include additional guidelines
Routine re-releases (4)
- 2025-04: 1 release · 1 Apr 2025
Commercial outcome & contract awards
Pipeline notice- Awards (0)
- No award published
- Contracts (0)
- No contract published
- Bid statistics
- No aggregate bid statistics published
Contracting authority & participating public bodies
Official documents & specifications (4)
Official links; attachments are not copiedNotices published for this procedure
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender